Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0743
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction ; day:12 ; month:5 ; year:2021 ; pages:1-7
The international journal of cardiovascular imaging ; (12.5.2021), 1-7
- Creator
-
Garg, Pankaj
Lewis, Robert A.
Johns, Christopher S.
Swift, Andrew J.
Capener, David
Rajaram, Smitha
Thompson, A. A. Roger
Condliffe, Robin
Elliot, Charlie A.
Charalampopoulos, Athanasios
Hameed, Abdul G.
Rothman, Alexander
Wild, Jim M.
Kiely, David G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10554-021-02279-z
- URN
-
urn:nbn:de:101:1-2021091218553760390498
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garg, Pankaj
- Lewis, Robert A.
- Johns, Christopher S.
- Swift, Andrew J.
- Capener, David
- Rajaram, Smitha
- Thompson, A. A. Roger
- Condliffe, Robin
- Elliot, Charlie A.
- Charalampopoulos, Athanasios
- Hameed, Abdul G.
- Rothman, Alexander
- Wild, Jim M.
- Kiely, David G.
- SpringerLink (Online service)
Other Objects (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction based on aging and comorbidities
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction based on aging and comorbidities
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction based on aging and comorbidities